DoD Prostate Cancer, Clinical Consortium Award
- Posted
- May 20, 2025
- Closed
- September 2, 2025
- Program funding
- $32,500,000
- Expected awards
- 12
- Cost sharing
- No
- Instrument
- Cooperative Agreement, Grant
- Assistance listing
- 12.420
- Archives
- September 28, 2025
Program funding history
Awards made under Assistance Listing 12.420 across FY2025–FY2027, from public federal spending records.
- FY2025 obligated
- $1.3B
- FY2026 obligated
- $598.5M
- FY2027 (to date) obligated
- $0
- Awards in window
- 4,414
Top recipients: The Univeristy of Texas M.d. Anderson Cancer Center, Regents of the University of California, San Francisco, the, University of California, Los Angeles, Icahn School of Medicine at Mount Sinai, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Source: USAspending.gov · refreshed October 2026 · Program page: awards, recipients and the opportunities under this listing →
Synopsis
Summary: The fiscal year 2025 (FY25) Prostate Cancer Research Program (PCRP) Clinical Consortium Award (CCA) provides support to develop, maintain, and enhance the necessary collaborations and resources to rapidly execute phase 2 and/or phase 2-linked phase 1 (phase1/2) prostate cancer clinical trials. The primary intent of the PCRP Clinical Consortium Award is to combine the efforts of leading investigators across multiple institutions to expedite the clinical advancement of novel therapeutic interventions in prostate cancer to decrease the impact of the disease.
Distinctive Features:
· This award mechanism does not support the development of clinical protocols.
· Coordinating Center: This award mechanism supports one coordinating center, which will be responsible for development and maintenance of the consortium organizational structure, and also function as a Clinical Research Site.
· Clinical Research Sites: This award mechanism supports multiple clinical research sites, which will be responsible for clinical trial introduction and selection, patient accrual for consortium studies, data collection and timely submissions, meeting attendance, and adherence to the consortium’s operating procedures.
Who can apply
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
The official record
Grants.gov published the official terms and dates of this opportunity; this page keeps them as they were listed.
New to federal funding? How to read an announcement · Who can apply · How grants work
Tell me when this program posts again
This round has closed. One email the morning after this program is posted again under a new number (we watch for about two years), and one more about a week before that round closes (the next morning, if it is already closer than that). That is all this sends — it is not a newsletter signup.
Get grants like this every Tuesday — free
One email a week: the biggest new federal grants and what’s closing soon — the same list for everyone. Unsubscribe any time.
Similar grants
- DoW Breast Cancer, Clinical Research Extension Award
- DoW Traumatic Brain Injury and Psychological Health, Clinical Trial Award
- DoW Arthritis Clinical Research Award
- DoW Autism Clinical Trial Award
- DoW Vision, Clinical Trial Award
- DoW Spinal Cord Injury, Clinical Trial Award
Same-day alerts, matched to you
The free digest is weekly — the same list for everyone. Members get every open federal grant scored to their organization — and an alert the day a real match posts: we read every new posting the day it opens. Free for 30 days, then $29/mo. Card required, cancel any time before day 31.
Not ready for a subscription? A one-time Fit Report — $29 — scores every open federal grant to your organization once, by email within one business day.
See pricing